{
  "docId": "019de072-c7f4-719d-b60b-87ffd56a191c",
  "docSlug": "e58df8a62ccd3bd6cd3ca8f1cf8222ea",
  "documentTitle": "MindMed | Results Presentation Deck | 40 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 40,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "before_after",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 16,
  "notes": "The chart illustrates a clear divergence between maintenance and supervised withdrawal regarding the use of opioid agonists.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-c7f4-719d-b60b-87ffd56a191c/15",
  "deckHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c",
  "deckJsonHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c.json",
  "deckAnchorHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.52,
        "y": 0.7
      },
      "kind": "callout",
      "text": "Most supervised withdrawal programs do not offer opioid medications",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7208654-2673-4e76-b68d-81c61e48b684",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.55,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Percent of Admissions for Which Opioid Agonists were Planned",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2c654547-8310-46de-90e8-6ce784878e4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.14,
        "y": 0.16
      },
      "kind": "list",
      "text": "Benefits: Available, Patient preference, Continuum of care. Challenges: Poor withdrawal management, Risk of fatal overdose, No standardization",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b96678a3-74e3-4985-9f1e-30a8879c1274",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.7,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Dunn et al., 2019, JSAT",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b8e7739-c198-454a-829a-1e229b5be46a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.12,
        "y": 0.03
      },
      "kind": "title",
      "text": "Supervised Withdrawal Treatment",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3706e73-10d3-44bd-8d29-72130cb9764e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "f230597a-7244-436d-9e15-881cdebfcfae",
      "evidence": "Benefits: Available, Patient preference, Continuum of care. Challenges: Poor withdrawal management, Risk of fatal overdose, No standardization",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "126e73eb-c0e3-4bba-8bfc-17aa5c0036aa",
      "evidence": "Contrasts benefits and challenges of a specific treatment modality.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 16,
      "from": 15,
      "beatId": "e3c69f7d-68d1-4273-be24-8fb11b743b82",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "Slides 15-16 emphasize the need for new treatment options.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "27189123-b3dc-4127-9f52-f3bbab8e40fd",
      "evidence": "Slides 11-16 highlight the consequences of not addressing the opioid crisis.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing the opioid crisis?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}